News und Analysen
Walmart To Host Fourth Quarter Earnings Conference Call on Feb. 17, 2022
Walmart Inc. (NYSE: WMT) today announced it will hold a live conference call with the Investment Community at 7 a.m. CST on Thursday, Feb. 17, 2022, to discuss the company’s fourth quarter earnings
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Pfizer’s Hospital leadership team – Angela Lukin, Global President; Annaliesa Anderson
Advisory: 2022 Chevron Investor Day
Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its annual investor day on Tuesday, March 1, 2022, at 10:00 a.m. ET (7:00 a.m. PT).
The meeting will
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
Pfizer Inc. (NYSE: PFE) reported strong financial results for fourth-quarter and full-year 2021 and provided 2022 total company financial guidance(4). In addition, Pfizer raised its previous 2022
American Express Chief Financial Officer to Participate in KBW Fintech Payments Conference
American Express Company (NYSE: AXP) Vice Chairman and Chief Financial Officer Jeffrey C. Campbell will participate in the Keefe, Bruyette & Woods (KBW) Fintech Payments Conference in New York on
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that following a request from the U.S. Food and Drug Administration (FDA) the companies have initiated a rolling submission
Pfizer Announces New Chief Development Officer
Pfizer Inc. (NYSE: PFE) today announced that William Pao, M.D., Ph.D., will join the Company as Executive Vice President and Chief Development Officer effective March 21, 2022. Dr. Pao will be a
ExxonMobil Streamlines Structure to Enhance Effectiveness, Grow Value, Reduce Costs
ExxonMobil said today it is further streamlining its business structure by combining chemical and downstream companies and centralizing technology and engineering, and other support services, to
Quartalsrekord für Apple!
ExxonMobil Appoints Jennifer Driscoll as Vice President of Investor Relations; Stephen Littleton to Retire
ExxonMobil said today that Jennifer Driscoll has been appointed vice president of investor relations, effective Feb. 7, replacing Stephen Littleton, who has elected to retire after 30 years of
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) granted marketing authorization for LORVIQUA® (lorlatinib, available in the U.S. under the brand name LORBRENA®) as
Chevron Announces Fourth Quarter 2021 Results
Chevron Corporation (NYSE: CVX) today reported earnings of $5.1 billion ($2.63 per share - diluted) for fourth quarter 2021, compared with a loss of $665 million ($(0.33) per share - diluted) in
American Express Declares Dividend on Series D Preferred Stock
American Express Company (NYSE:AXP) declared a quarterly dividend on the Company’s 3.550% Fixed Rate Reset Noncumulative Preferred Shares, Series D, of $8,875 per share (which is equivalent to
Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the conditional
Exxon Mobil Corporation Declares First Quarter Dividend
The Board of Directors of Exxon Mobil Corporation today declared a cash dividend of $0.88 per share on the Common Stock, payable on March 10, 2022 to shareholders of record of Common Stock at the
Chevron Increases Quarterly Dividend
The Board of Directors of Chevron Corporation (NYSE: CVX) today declared a quarterly dividend of one dollar and forty-two cents ($1.42) per share, an increase of eight cents ($0.08) per share or
Chevron Introduces ‘Keep Clean Preferred Vendor Program’ to Offer Lubricant Performance and Anti-Contamination Services to Customers Post-Purchase
Chevron Products Company, a division of Chevron U.S.A. Inc., today announced the launch of the Keep Clean Preferred Vendor Program to provide customers with the tools and services to make the most
ExxonMobil to Release Fourth Quarter 2021 Financial Results
Exxon Mobil Corporation will release fourth quarter 2021 financial results on Tuesday, February 1, 2022. A press release will be issued via Business Wire and available at 6:30 a.m. CT at www.exxonm
American Express Fourth-Quarter Revenue Increases 30% to $12.1 Billion, Driven By Record Card Member Spending
American Express Company (NYSE: AXP) today reported fourth-quarter net income of $1.7 billion, or $2.18 per share, compared with net income of $1.4 billion, or $1.76 per share, a year ago.
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine
American Express to Hold 2022 Investor Day
American Express Company (NYSE: AXP) will hold an Investor Day on March 16, 2022, beginning at 1 p.m. Eastern. Chairman and Chief Executive Officer Stephen J. Squeri, Vice Chairman and Chief
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License
ExxonMobil Announces Ambition for Net Zero Greenhouse Gas Emissions by 2050
ExxonMobil today announced its ambition to achieve net zero greenhouse gas emissions for operated assets by 2050, backed by a comprehensive approach to develop detailed emission-reduction roadmaps
U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved CIBINQO® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for